Silver Book Fact

According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.

Houston, Kerri. Innovative Drugs Cost Patients Less in the Long Run. Chicago Sun Times. 30-Jul-2004

Reference

Title
Innovative Drugs Cost Patients Less in the Long Run
Publication
Chicago Sun Times
Publication Date
30-Jul-2004
Authors
Houston, Kerri

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Statin treatment soon after an acute heart attack reduces the risk of fatal heart disease or a recurrent heart attack by 24%.  
  • Survival rates of SAS patients ages 80+ with and without SAVR
     
  • Since 1950, reduction in heart disease mortality has added more than 3 1/2 years to the expected lifetimes of both men and women.  
  • Between 1981 and 2004, death rates for heart disease and stroke declined by about 44%.  
  • Effect of optimal anticoagulation
    If 50% of atrial fibrillation patients who currently receive warfarin in routine medical care were optimally anticoagulated, 9,852 emboli would be prevented and $1.3 billion would be saved each year.